Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Saad Usmani

Myeloma · MSK

View

Dr. Kamal Menghrajani

Leukemia · MGH

View

Dr. Hope Rugo

Breast Oncology · City of Hope

View

Dr. Gideon Dosunmu

GI Oncology · Emory Hospital Midtown

View

Dr. Pavlos Msaouel

GU Oncology · MD Anderson Cancer Center

View

Dr. Virginia Borges

Breast Oncology · CU Anschutz Medical Campus

View

Dr. Naval Daver

Leukemia · MD Anderson Cancer Center

View

Dr. William Gradishar

Breast Oncology · NU

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    HMDr. Hemant Murthy
    Leading Voice

    Dr. Hemant Murthy

    Hematology & Oncology · Bone Marrow Transplant (BMT)
    Mayo Clinic in Florida
    hemant
    Jacksonville, FL, USA

    Research

    Variants in DENND2B are associated with vulnerability for neurodevelopmental impairment, psychosis and catatonia

    2026

    Via Brain

    Research

    Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 study

    2026

    Via bioRxiv

    Research

    Cancer CARE (Connected Access and Remote Expertise) Beyond Walls - Safety, Feasibility, and Patient Experience of Home-Based Chemotherapy

    2026

    Via NEJM Catal Innov Care Deliv

    Research

    CPX-351 (Liposomal Cytarabine and Daunorubicin) versus venetoclax plus hypomethylating agent therapy in newly diagnosed acute myeloid leukemia: a retrospective comparison involving 600 Mayo Clinic patients

    2026

    Via Blood Cancer J

    Research

    Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomas

    2026

    Via Blood Neoplasia

    Research

    Clinical outcomes of venetoclax combined with hypomethylating agents versus hypomethylating agents alone in TP53-mutated myelodysplastic syndromes

    2026

    Via Haematologica

    Research

    Comparative Efficacy of Donor Lymphocyte Infusions in Augmenting Graft-versus-Leukemia Effect after Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Myeloid Malignancies

    2026

    Via Acta Haematol

    Research

    Infections Within 100 Days of Idecabtagene Vicleucel and Impact on Survival for Relapsed/Refractory Multiple Myeloma: A CIBMTR Analysis

    2026

    Via Transplant Cell Ther

    Research

    Characteristics of clonal cytopenia of undetermined significance in the presence of ZRSR2 mutations

    2026

    Via Haematologica

    Research

    Weekly Metronomic Venetoclax and Decitabine/Cedazuridine in Acute Myeloid Leukemia Patient Declining Blood Transfusion

    2026

    Via Case Rep Oncol

    Research

    Optimizing Diagnostic Precision: Patient Selection and Diagnostic Endoscopy in Gastrointestinal Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplant

    2026

    Via J Gastrointestin Liver Dis

    Research

    Adopting a Standard of Care for Systemic Sclerosis: The Mayo Clinic Experience

    2026

    Via Arthritis Care Res (Hoboken)

    Research

    Prognostic Factors for Early Mortality Following Allogeneic Hematopoietic Cell Transplantation in Hematologic Malignancies

    2026

    Via Transplant Cell Ther

    Research

    Impact of Conditioning Regimen Intensity and Total Body Irradiation on Outcomes of Allogeneic Hematopoietic Cell Transplantation for Mature T-Cell Lymphomas: A Multicenter Analysis

    2026

    Via Transplant Cell Ther

    Research

    Hematopoietic Cell Transplantation for Blastic Plasmacytoid Dendritic Cell Neoplasm: Clinical Practice Guidelines From the American Society for Transplantation and Cellular Therapy

    2026

    Via Transplant Cell Ther